Maternal blood -based microRNA transcripts as biomarkers for detecting risk of spontaneous preterm birth: a nested case-control study.

Objective: Both genetic variants and maternal blood mRNA levels of EBF1 gene have been linked to sPTB. Animal and human studies suggest that specific EBF1-based miRNAs are involved in various physiological and pathophysiological processes. However, to date, we did not find any reports of EBF1-based...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Maternal-Fetal & Neonatal Medicine Vol. 33; no. 7; pp. 1 - 10
Autores principales: Zhou, Guoli, Holzman, Claudia, Heng, Yujing J, Kibschull, Mark, Lye, Stephen J
Formato: Journal Article
Publicado: Taylor & Francis Ltd Apr2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=142544827&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 142544827
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14767058
        O6A
      jtl: Journal of Maternal-Fetal & Neonatal Medicine
      issn: 14767058
      maglogo: Y
    pubinfo:
      dt: Apr2020
      vid: 33
      iid: 7
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        142544827
        142544827
        145570030
        NLM32237936
        10.1080/14767058.2020.1745178
        NLM32237936
        142544827
      ppf: 1
      ppct: 9
      formats:
      tig:
        atl: Maternal blood -based microRNA transcripts as biomarkers for detecting risk of spontaneous preterm birth: a nested case-control study.
      aug:
        au:
          Zhou, Guoli
          Holzman, Claudia
          Heng, Yujing J
          Kibschull, Mark
          Lye, Stephen J
        affil: Biomedical Research Informatics Core, Clinical & Translational Sciences Institute, Michigan State University, East Lansing, MI, USA
      sug:
        subj:
          Childbirth, Premature
          Childbirth, Premature Diagnosis
          RNA
          Case Control Studies
          Female
          Proteins
          Infant, Newborn
          Alberta
          Pregnancy
          Checklists
          Scales
          Questionnaires
          Infant, Newborn: birth-1 month
          Female
      ab: Objective: Both genetic variants and maternal blood mRNA levels of EBF1 gene have been linked to sPTB. Animal and human studies suggest that specific EBF1-based miRNAs are involved in various physiological and pathophysiological processes. However, to date, we did not find any reports of EBF1-based miRNAs or miRNA transcripts in relation to sPTB. We therefore aimed to examine whether maternal blood early B cell factor 1 (EBF1) gene-based microRNA (miRNA) transcripts can be used for detecting risk of spontaneous preterm birth (sPTB).Methods: We conducted a nested case-control study within a Canadian cohort consisting of 1878 singleton pregnancies enrolled from May 2008 to December 2010 in Calgary, Alberta, Canada. We used a public gene expression dataset (GSE59491) derived from maternal blood in trimesters 2-3 that included women with sPTB (n = 51) and term births (n = 106) matched for maternal age, race/ethnicity, pre-pregnancy body mass index, smoking during pregnancy, and parity within the Canadian cohort. Two bioinformatics tools, miRWalk and STarMirDB, with different algorithms were applied to retrieve miRNA transcripts that putatively target the EBF1 gene (i.e. EBF1-based). Limma moderated t-tests were used to examine differentially expressed (DE) miRNA transcripts (sPTB vs term) within trimesters. Logistic regression models with miRNA transcript tertiles were applied to assess threshold associations between candidate miRNA transcripts' levels and sPTB. Receiver operating characteristic (ROC) analyses were used to identify the maximum Youden Index and its corresponding optimal sensitivity/specificity cut-point of EBF1-based miRNA transcripts for classifying sPTB, and to compare the classification performance of a linear combination (score) of miRNA transcripts with that of individual miRNA transcripts. A five-fold cross-validation was applied to examine the possible overfitting problem of the final ROC model.Results: Four maternal blood EBF1-based miRNA transcripts (MIR4266, MIR1251, MIR601, MIR3612) in the 3rd trimester were significantly associated with sPTB. The odds ratios (95%CIs) for highest versus lowest tertile of the four miRNA transcripts were 3.01-5.25(1.21-13.14, p ≤ .018). The combined 4-miRNA transcripts' score significantly improved the classification of sPTB compared to individual miRNA transcripts (AUC increased from 0.65-0.69 to 0.82, p ≤ .0034) and showed a sensitivity for sPTB of 0.81 and a specificity of 0.72. The final ROC model of the EBF1-based 4 miRNA transcripts' score in cases and controls had no significant overfitting issue.Conclusions: Maternal blood EBF1-based miRNA transcripts may, along with other biomarkers, be useful in screening for sPTB risk in 3rd trimester. Our results also provide clues for further study of potential molecular mechanisms underlying the relationship between EBF1 gene and sPTB, e.g. connecting genetic variants, mRNA expression, and miRNA regulation.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N